Past year
All results
- All results
- Verbatim
6 days ago · the RASSF1A p.A331S polymorphism is not confirmed as a significant germline contributor to familial breast cancer susceptibility. High levels of methylation ...
Oct 15, 2024 · Inherited mutations in BRCA1 and this gene, BRCA2, confer increased lifetime risk of developing breast or ovarian cancer.
Dec 31, 2023 · We assessed the expression of RASSF1A, DIRAS3, and AKAP9 genes, and the presence of BRAF V600E point mutation in benign and malignant thyroid lesions in a ...
Nov 20, 2023 · Notably, the expression levels of RASSF1A are associated with increased cancer risk and poor clinical outcomes [41]. Recent studies have also demonstrated the ...
Jul 19, 2024 · This review provides an overview of common assays used to screen for gene methylation and early biomarkers of methylation in various cancers.
Jun 20, 2024 · We report on an interpretable machine learning model that can classify 13 cancer types as well as non-cancer tissue samples using only DNA methylome data, with ...
Jun 15, 2024 · Neurofibromatosis type 2 (NF2) is a tumor suppressor gene implicated in various tumors, including mesothelioma, schwannomas, and meningioma.
May 31, 2024 · FoxP3 gene polymorphism is associated with breast cancer in Iranian patients. ... RASSF1A promoter methylation levels positively correlate with estrogen ...
Apr 29, 2024 · In a previous systematic review, it was observed that BRCA1 and RASSF1A were the most frequently investigated genes in whole blood and plasma, respectively.
Jan 26, 2024 · Epigenetic regulation, has been very scarcely explored in familial breast cancer (BC). In the present study RASSF1A and RAR beta promoter methylation and miR17, ...